DKSH Hong Kong and Sumitomo Pharmaceuticals Asia Pacific Sponsor The 7th Asian Congress of Schizophrenia Research September 15, 2021


			
				DKSH Hong Kong and Sumitomo Pharmaceuticals Asia Pacific Sponsor The 7th Asian Congress of Schizophrenia Research

DKSH Hong Kong joined hands with Sumitomo Pharmaceuticals Asia Pacific to support the Hong Kong Schizophrenia Research Society of the University of Hong Kong in organizing the biennial international conference held in September.

Media release 

DKSH Hong Kong and Sumitomo Pharmaceuticals Asia Pacific Sponsor The 7th Asian Congress of Schizophrenia Research

DKSH Hong Kong joined hands with Sumitomo Pharmaceuticals Asia Pacific to support the Hong Kong Schizophrenia Research Society of the University of Hong Kong in organizing the biennial international conference held in September.

Hong Kong, September 15, 2021 – DKSH Business Unit Healthcare, Asia’s leading partner for healthcare companies seeking to grow their business in Asia and beyond, partnered with its longstanding client, Sumitomo Pharmaceuticals Asia Pacific Pte. Ltd. (hereinafter “Sumitomo Pharmaceuticals Asia Pacific”), to become the sponsors for the 7th Asian Congress of Schizophrenia Research (ACSR) under this year’s theme: Psychosis Research and Intervention in a Changing World. The virtual congress targeted around 1,000 psychiatrists from Hong Kong – including those from the hospital authority – and around the world.

 

The two-day congress hosted professors, doctors, and medical experts from Belgium, Canada, China, Germany, Hong Kong, Indonesia, Italy, Japan, Korea, Malaysia, Mongolia, Portugal, the United Kingdom, the United States, Singapore, Taiwan, and Thailand. A series of symposiums were organized to share insights on the subject matters from cognition, psychosis studies and treatment to schizophrenia diagnosis and early intervention.

 

DKSH Hong Kong and Sumitomo Pharmaceuticals Asia Pacific hadinvited Dr Wai-Song Yeung from Pamela Youde Nethersole, Eastern Hospital, Hong Kong, and Professor Christoph U. Correll from Institute of Behavioral Science, Feinstein Institutes for Medical Research, United States, to discuss in a sponsored symposium on “Early-Onset Schizophrenia – diagnosis, early intervention,and optimization of outcomes”.

 

Xie Xinyan, Regional Product Manager of Sumitomo Pharmaceuticals Asia Pacific, said: "DKSH Hong Kong is a trusted business partner for us. We are pleased to work with the DKSH team to participate in congresses that will enhance the quality of scientific education for our physicians, thereby benefitting patients in the long term.”

 

Wai Ting Fong, Head of Management and Vice President of Healthcare, DKSH Hong Kong & Macau, was equally pleased to partner with Sumitomo Pharmaceuticals Asia Pacific for the sponsorship: “DKSH Hong Kong has been very keen to participate and support international healthcare congresses and conventions. Through engaging with the medical practitioners around the world, we can gather and introduce advanced healthcare products, services, and treatments to patients in Hong Kong and Macau.”